Skip to content

MEDACCOR

Active
Private limited companyfounded 2015active for 11 yearsChemin d'Orange(V.P) 12, 7322 Bernissart, BelgiumKBO/BCE: BE 0628.643.340
Summary

MEDACCOR has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €491,313 and a net result of €54,895. Equity is growing by about 46% per year across the filed financial years. Its solvency ranks better than 22% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
MEDACCORActiveChecked score 86/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€2.1mtotal assets 2025
Equity
€491,313
Profit
€54,895
Turnover not published (micro format)
Financial health
86 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Accounts filed 60 days late1 of 2 deeds read
Why 86raises riskLatest accounts 60 days late; 3 of the last 3 lateLiquidity: current ratio 2.47, cash €17,270lowers riskSize: total assets €2.1mSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 27% of its sector peers (NACE 86, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 48-3
equity 23.5% of total assets
Liquidity 51-1
short-term debt 5.3% · cash 0.8%
Profitability 51-28
return on assets 2.6%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.1%▼ -0.2 percentage points vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.2 percentage points vs 07-2026 09-2026: 0.4%● unchanged vs 08-2026highest value 10-2026: 0.2%▼ -0.2 percentage points vs 09-2026
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.47, compared with 13.43 in 2024, above the usual 1.5; short-term debt: 5.3% and cash: 0.8% of total assets), but 76.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 12% on solvency, 23% on liquidity, 11% on profitability and 64% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Latest accounts 60 days late; 3 of the last 3 late
NBB · filings
raises risk · Liquidity: current ratio 2.47, cash €17,270
NBB · annual accounts
lowers risk · Size: total assets €2.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 20598 sector peers (2025).
NBB · sector comparison
Position among 20598 sector peers
Solvency
better than 22%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-09-2026, 60 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 9 filings
Deviation from the deadline
2025
60 days late
2024
54 days late
2023
39 days late
2022
29 days late
2021
30 days late
2020
29 days late
2019
44 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 28 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 September (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €138,114 ▲37.4%

Key points

  • Caution: Result fell in 2025from €138,114 to €54,895 ▼ 60.3% View
  • Positive: Among the best 19% on equitysector median €124,488 · 20,600 companies €491,313 View
  • Positive: 7 profitable years in a rowprofit 2025: €54,895 7 years View

By topic

Financials

Financial year
2025
Total assets
€2.1m
Profit
€54,895
Solvency
23.5%
Total assets▲ 22.5%
Net result
20182025
Go to Financials

Timeline

Events
17
Since
2018
Next accounts
by 31-07-2027
  1. 31-12-2024Liquidity more than 11 times
  2. 08-09-2024Annual accounts filed
  3. 31-12-2023Equity above €200,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
16-04-2015
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about MEDACCOR

What is the company number of MEDACCOR?
0628.643.340. In Belgium the VAT number is the company number with BE in front: BE 0628.643.340.
Where is MEDACCOR based?
The registered office is at Chemin d'Orange(V.P) 12, 7322 Bernissart.Company details
What does MEDACCOR do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDACCOR?
Private limited company (BV).
When was MEDACCOR founded?
On 16-04-2015.
Is MEDACCOR still active?
Yes, MEDACCOR is an active enterprise in the KBO register.
What is the turnover of MEDACCOR?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is MEDACCOR profitable?
In financial year 2025, MEDACCOR made a profit of €54,895.
Where can I find the annual accounts of MEDACCOR?
MEDACCOR filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDACCOR due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to MEDACCOR

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure